Executive Appointment

Lisle, Ill. – – September 30, 2026 -- Forum Health, LLC has appointed Elizabeth Campbell as Chief Financial and Development Officer, a newly created role tasked with leading fundraising and acquisitions as the functional medicine network pursues rapid expansion.

Campbell joins after building and selling a 88-clinic orthodontic platform

Campbell co-founded myOrthos, LLC in 2019 and served as CEO, completing 37 acquisitions to build a platform of 88 clinics across 14 states before its 2025 sale to Smile Doctors, a portfolio company of TH Lee. She brings more than 20 years of experience spanning The Boston Consulting Group, private equity roles at SV Life Sciences Advisors and LLR Partners, and healthcare operating leadership.

Lincoln, Neb. – September 30, 2026 -- Assurity has appointed Draper Daniel as Vice President of Customer Connections, placing him in charge of the insurer's customer service operations and experience strategy.

Daniel brings 28 years of insurance industry leadership to the role

Daniel has spent more than 28 years in the insurance sector, with a track record in operational leadership and business transformation. He has previously managed large customer service organizations and led high-performing teams focused on operational improvement.

Assurity executive cites fit with company's continuous improvement culture

Tara Benson, Assurity's Senior Vice President of Operations, said Daniel's experience combining people, process, technology and strategy would help the company evolve how it serves customers and distribution partners.

Kelowna, BC – September 30, 2026 -- Doseology Sciences Inc. (CSE: MOOD, OTCQB: DOSEF, FSE: VU70) has appointed Kareem Baalbaki as interim CEO, interim CFO and director, alongside Jeremy Wright as a new board director, replacing outgoing CEO Chris Jackson and CFO Chris Cherry, who have both resigned.

Baalbaki scaled a Canadian CPG operator's revenue fifteenfold before joining Doseology

Baalbaki previously served as Chief Supply Chain Officer at Revive Superfoods, where he helped grow the frozen CPG platform's annual revenue from approximately $10 million to $150 million. The Toronto-based executive holds more than a decade of operations and supply-chain experience, including restructuring underperforming businesses and advising boards on governance and organizational design. He holds a Master of Science in International Business from the University of Lincoln in the United Kingdom.

Point Pleasant, N.J. – September 30, 2026 -- Paladone WeCool has appointed Matthew Lauderbach as Product Development Director, bringing more than 25 years of toy design experience to the company's US operations.

Lauderbach brings leadership experience from Fisher-Price, Spin Master and Just Play

Lauderbach's career spans leadership roles at Fisher-Price, Spin Master, Skip Hop and Just Play, with expertise covering concept creation, design management, engineering and commercialization.

Executive says he was already a fan of the Compound Kings and iLY Sticker Maker lines

In his new role, Lauderbach said he had admired Paladone WeCool's product range prior to joining, citing the Compound Kings and iLY Sticker Maker product lines as examples of the company's approach to hands-on play.

Shreveport, La. – September 30, 2026 -- Pathology Ventures, LLC (PVL), a physician-founded network representing more than 500 pathologists, has appointed Dominic Stockey as executive vice president to lead partnerships with pharmaceutical, diagnostic and research sponsors.

Former investment banker to run sponsor and enterprise development

Stockey joins PVL after seven years in investment banking, where he served as Vice President and worked on more than 15 closed transactions across diagnostics, life sciences and healthcare, including mergers and acquisitions and capital formation deals. At PVL, he will oversee business operations, sponsor and partner relationships, commercialization, contracting and program execution.

New York – September 30, 2026 -- MyComplianceOffice (MCO), a compliance management software provider for financial services, has appointed John Schobel as President, adding a 25-year RegTech veteran to lead its global go-to-market strategy following a $100 million-plus strategic financing round.

MCO's revenue climbed 22% from 2024 to 2025 as client base expanded

The compliance software firm now serves more than 1,500 client companies across over 125 countries, onboarding more than 100 new firms during the same period. The growth trajectory coincides with recent strategic growth financing from Accel-KKR Credit Partners, which MCO says will fund continued expansion and product development.

Washington – September 29, 2026 -- The Pharmaceutical Research and Manufacturers of America (PhRMA) has named former House Majority Leader Eric Cantor as its next president and chief executive officer, effective November 9. Cantor succeeds Stephen J. Ubl, who has led the trade group since 2015 and will remain as a strategic advisor through January 15, 2027.

New York – September 29, 2026 -- MSIG USA has appointed Oscar Aguilar as head of excess and surplus property, tasking him with building out the insurer's E&S property platform for brokers navigating complex commercial risk.

Broomfield, Colo. – September 29, 2026 -- Horizon Family Brands has promoted Scott Wallace to Chief Customer Officer, expanding his mandate to oversee customer strategy and retail partnerships across its organic dairy portfolio, which includes Horizon Organic, Maple Hill Creamery and Wallaby Organic yogurt.

Wallace moves from senior sales leadership to a company-wide customer strategy role

Wallace joined Horizon Family Brands in November 2023 as vice president of sales and was elevated to senior vice president in 2025. In his new CCO role, he will coordinate across sales, marketing, operations and brand teams to deepen customer engagement and identify shared growth opportunities across the company's retail and commercial networks.

Nashville, Tenn. – – September 29, 2026 -- Thyme Companies has appointed Carolyn Starrett as executive vice president of new ventures, tasking her with identifying and scaling new businesses beyond its existing Thyme Care platform. Starrett reports directly to Executive Chairman Robin Shah, marking her second collaboration with him after their tenure together at Flatiron Health.

Starrett brings a decade of oncology data leadership from Flatiron Health

Starrett joined Flatiron Health in 2016 alongside Thyme's founders and served as its Chief Executive Officer from 2021 to 2025. Under her leadership, Flatiron's real-world evidence platform expanded from roughly 400,000 to more than 5.5 million patient records. Its OncoEMR platform grew to serve more than 4,500 oncology providers nationwide, while the company extended research operations into the United Kingdom, Germany and Japan.